Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,400
Closed -$2.67M 10595
2025
Q4
$2.67M Buy
21,400
+8,900
+71% +$1.06M ﹤0.01% 4688
2025
Q3
$1.5M Buy
+12,500
New +$1.32M ﹤0.01% 5234
2025
Q1
Sell
-601,400
Closed -$55.6M 10286
2024
Q4
$55.6M Buy
601,400
+551,400
+1,103% +$53.1M 0.01% 1366
2024
Q3
$4.64M Hold
50,000
﹤0.01% 3152
2024
Q2
$3.75M Sell
50,000
-6,800
-12% -$543K ﹤0.01% 3133
2024
Q1
$4.9M Buy
56,800
+6,800
+14% +$520K ﹤0.01% 2995
2023
Q4
$3.46M Buy
+50,000
New +$3.02M ﹤0.01% 3179
2022
Q1
Sell
-130,400
Closed -$6.88M 10334
2021
Q4
$6.88M Buy
+130,400
New +$6.43M ﹤0.01% 2491

Other funds holding CRH

UBS Group's CRH Position: Q1 2026 in Review

UBS Group reduced its CRH (CRH) stake by 38% in Q1 2026, selling an estimated $282M and leaving 3,944,361 shares worth $415M. The position accounts for 0.06% of the portfolio, ranked #313.

UBS Group first reported a position in CRH in Q4 2014 and has held it in 46 quarters since. The position peaked at $874M in Q1 2025. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • UBS Group held 3,944,361 shares of CRH worth $415M as of Q1 2026.
  • UBS Group sold 2,399,531 CRH shares in Q1 2026, an estimated $282M.
  • CRH made up 0.06% of UBS Group's portfolio in Q1 2026, its #313 holding.
  • UBS Group first reported a position in CRH in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's CRH position peaked at $874M in Q1 2025.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.